Clinical Trial Update: Effects of DHA in Patients With Multiple Sclerosis [NA]

View source ↗

Summary

This clinical trial update describes evaluating the effects of docosahexaenoic acid (DHA) in patients with multiple sclerosis, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• DHA (docosahexaenoic acid) (docosahexaenoic acid)

Snippet

Sponsor: Francisco Javier Martínez Noguera | Conditions: Multiple Sclerosis, Performance Enhancement | NA | Status: ENROLLING_BY_INVITATION